AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2011
May 25, 2011
34301_dirs_2011-05-25_f2463d80-c64b-487a-b944-2be9410ddd56.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2011-05-20
Reporting Person: Dean Lloyd H (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-05-20 | Common Stock | P | 1336 | $5.27 | Acquired | 1336 | Indirect |
| 2011-05-20 | Common Stock | P | 164 | $5.28 | Acquired | 1500 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Restricted Stock | 21000 | Direct |
Footnotes
F1: These shares are owned by Lloyd H. Dean,TTE and Suzanne R. Dean, TTE, U/A DTD 8/13/2002, the Dean Family Trust.
F2: The restricted stock vests fifty percent (50%) on November 1, 2011 and fifty percent (50%) on November 1, 2012, subject to Mr. Dean's continued service to the Company.
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26